Regents’ Patent on Live Salmonella Vaccine Fails to Meet Disclosure Requirements, Court Rules

Regents’ Patent on Live Salmonella Vaccine Fails to Meet Disclosure Requirements, Court Rules Featured image for Regents’ Patent on Live Salmonella Vaccine Fails to Meet Disclosure Requirements, Court Rules

The Delhi High Court recently upheld the Controller of Patents' decision to reject an appeal filed by the Regents of the University of California (hereafter...

Read more about Regents’ Patent on Live Salmonella Vaccine Fails to Meet Disclosure Requirements, Court Rules

Frivolous inventions and abstract theories – Delhi High Court refuses patent appeal

Frivolous inventions and abstract theories – Delhi High Court refuses patent appeal Featured image for Frivolous inventions and abstract theories – Delhi High Court refuses patent appeal

The Delhi High Court dismissed an appeal against the rejection of a patent application due to lack of novelty and a significant procedural delay of 701 days. The appellants, who had filed a patent application for black-colored wearables with claimed effects on human energy, failed to provide scientific evidence or technical merit. The court upheld the Indian Patent Office’s decision, emphasizing that abstract ideas are not patentable and reaffirming the importance of adhering to statutory deadlines for appeals.

Read more about Frivolous inventions and abstract theories – Delhi High Court refuses patent appeal

Methods for Antibody Production in Genetically Modified Animals are Patentable; they are not covered under Section 3(i) Exclusion

Methods for Antibody Production in Genetically Modified Animals are Patentable; they are not covered under Section 3(i) Exclusion Featured image for Methods for Antibody Production in Genetically Modified Animals are Patentable; they are not covered under Section 3(i) Exclusion

The Madras High Court has overturned the rejection of Kymab Limited’s patent application related to generating antibodies in non-human mammals. The Court found that the invention does not fall under Section 3(i) of the Patents Act, 1970, as it is not a method for treating animals but a process for producing antibodies using genetically modified animals. The patent is now set to be granted.

Read more about Methods for Antibody Production in Genetically Modified Animals are Patentable; they are not covered under Section 3(i) Exclusion

Rejecting Patent Applications without Comprehensive Analysis Contradicts Section 2(1)(ja) of the Patents Act, says Delhi High Court

Rejecting Patent Applications without Comprehensive Analysis Contradicts Section 2(1)(ja) of the Patents Act, says Delhi High Court Featured image for Rejecting Patent Applications without Comprehensive Analysis Contradicts Section 2(1)(ja) of the Patents Act, says Delhi High Court

The Delhi High Court, in the matter of Saint Gobain Abrasives Inc & Anr vs the Controller of Patents, accepted an appeal challenging the refusal...

Read more about Rejecting Patent Applications without Comprehensive Analysis Contradicts Section 2(1)(ja) of the Patents Act, says Delhi High Court